Despite great progress over the past years, tuberculosis (TB) remains a major global health problem. In 2013, an estimated 9.0 million people developed TB and 1.5 million died from the disease, according to the World Health Organization (WHO). The number of TB deaths is unacceptably large given that most are preventable.
Despite the loss of millions of lives, TB remains one of the most neglected diseases by pharmaceutical companies due to its lack of commercial potential. Fighting TB is one of Sandoz’s leading corporate responsibility initiatives.
Our dedicated TB website: tbdots.com
To help increase awareness of the global TB health problem and provide resources to those who are interested in joining the fight, Sandoz provides a dedicated TB website, tbdots.com. Visit tbdots.com to learn more about TB, Sandoz’s fight against it, and to read our free TB scientific journal, SPIRITUS.
Partnerships with local health authorities support community engagement programs to raise awareness, provide preventive solutions and counter many myths surrounding tuberculosis.
In 2013, the Sandoz Global TB team cooperated with the Indian Ministry of Health to create an awareness film on the management of tuberculosis in public health centers where the WHO's DOTS (directly observed treatment short course) strategy is implemented. These public health centers are run under the guidance of the National TB control program of India and provide medical consultation, diagnosis and treatment for TB patients, free of cost. The film reiterates the importance of early diagnosis and completion of treatment.